Management Team
Berno Maaswinkel
Chief Executive Officer
“Loosing sight affects almost everything in life. We would like to help.”
Carel Hoyng
Senior Clinical Scientist, Founder, Key opinion leader Retinal Disease
“My ultimate goal is to find a cure for inherited retinal diseases”
Rob Collin
Chief Scientific Officer, Founder, Inventor RNA Therapy
“Due to their high specificity, antisense oligonucleotides hold great promise to correct RNA defects underlying many inherited diseases”
Employees
Erwin van Wijk
Senior Scientist
"Being able to save vision will be a life-changing event for people with a blinding disorder"
Irene Vázquez Domínguez
Postdoctoral Researcher
"It is very important to reach new paths to make the distance between bench and bed shorter"
Tom Koemans
Clinical Research Associate
"I like to contribute to the development of these innovative RNA therapies and to treat and cure degenerative diseases of the retina. By this, I hope to improve health care worldwide. "
Femke Bukkems
Research technician
"By researching treatment for retinal disorders, I hope to help and eventually cure patients with these diseases so that they can once again enjoy all that is happening around them."
General advisors
Markwin Velders
General Advisor
Dr. Markwin Velders obtained his PhD in molecular immunology at the Leiden University and worked as scientist and assistant professor at Loyola University Chicago, authoring over 40 peer reviewed papers.…
Maarten Scholten
General Advisor
After obtaining his law degree at the University of Amsterdam (The Netherlands), Mr. Scholten started his career as an attorney at the Amsterdam and New York offices of Loeff &…
Lucy Peltenburg
General Advisor
After obtaining her PhD in molecular biology of cancer at the University of Leiden, Dr. Lucy Peltenburg worked as a post-doc at the Biology department at the University of California…